Early immune surveillance to predict cytomegalovirus outcomes after allogeneic hematopoietic stem cell transplantation

BACKGROUND: There is no method of predicting human cytomegalovirus (HCMV) outcomes in allogeneic hematopoietic stem cell transplant recipients clinically, leading in some cases to excessive or insufficient antiviral therapy. We evaluated the early immune response of recipients with disparate HCMV ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Jintao, Li, Xuejie, Gui, Genyong, Wu, Jian, Gong, Shengnan, Shang, Yuxin, Fan, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382130/
https://www.ncbi.nlm.nih.gov/pubmed/35992173
http://dx.doi.org/10.3389/fcimb.2022.954420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382130/
https://www.ncbi.nlm.nih.gov/pubmed/35992173
http://dx.doi.org/10.3389/fcimb.2022.954420

Ejemplares similares